Filing Details

Accession Number:
0001179110-11-014797
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-03 17:25:59
Reporting Period:
2011-11-01
Filing Date:
2011-11-03
Accepted Time:
2011-11-03 17:25:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820237 Gen Probe Inc GPRO Surgical & Medical Instruments & Apparatus (3841) 330044608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419055 Ellerbrock Jorgine C/O Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego CA 92121
Senior Vp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-01 1,075 $42.66 5,427 No 4 M Direct
Common Stock Acquisiton 2011-11-01 925 $38.51 6,352 No 4 M Direct
Common Stock Disposition 2011-11-01 2,430 $58.19 3,922 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-11-01 1,075 $0.00 1,075 $42.66
Common Stock Stock Option (Right to Buy) Disposition 2011-11-01 925 $0.00 925 $38.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,725 2017-02-10 No 4 M Direct
8,125 2016-08-17 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2011.
  2. 25% of the shares subject to the stock option vested and became exercisable on February 10, 2011 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.
  3. 25% of the shares subject to the stock option vested and became exercisable on August 17, 2010 and the remaining shares subject to the stock option vest and become exercisable in equal monthly installments over the following three years.